A Case of Acquired Hemophilia A in a Patient with Exposure to COVID-19 | Zendy

Jorge D. Guerra | Zendy; Jasmine Gowarty | Zendy; Jordan Buess | Zendy; James R. Mason | Zendy; Kathleen Halka | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Case of Acquired Hemophilia A in a Patient with Exposure to COVID-19

Author(s) -

Jorge D. Guerra,

Jasmine Gowarty,

Jordan Buess,

James R. Mason,

Kathleen Halka

Publication year - 2022

Publication title -

case reports in hematology

Language(s) - English

Resource type - Journals

eISSN - 2090-6560

pISSN - 2090-6579

DOI - 10.1155/2022/9494249

Subject(s) - medicine , covid-19 , etiology , pandemic , pediatrics , intensive care medicine , virology , pathology , disease , outbreak , infectious disease (medical specialty)

Acquired Hemophilia A (AHA) is a very rare autoimmune condition involving immune-mediated depletion of Factor VIII, resulting in spontaneous hemorrhage. Failure to recognize AHA as a possible etiology of hemorrhage can result in delayed diagnosis and treatment. The COVID-19 pandemic has given rise to several hematologic conditions and complications, with a rare manifestation being Acquired Hemophilia A (AHA). An interesting case of AHA following SARS-CoV-2 infection is described, along with the treatment approach and a brief review of several cases describing AHA in association with COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research